MMS 📈 Maximus - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US5779331041
MMS: Government Services, Healthcare Solutions, Employment Services, Technology Solutions
Maximus, Inc. operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments. This segment also provides employment services, such as eligibility support, case management, job-readiness preparation, job search and employer outreach, job retention and career advancement, and educational and training services; technology solutions; system implementation project management services; and specialized consulting services. The U.S. Federal Services segment offers Business process services, eligibility and enrollment, outreach, and other services for federal health and human services programs; clinical services; and technology solutions, including application development and modernization services, enterprise business solutions, advanced analytics and emerging technologies, cybersecurity services, and infrastructure and engineering solutions. The Outside the U.S. segment offers BPS solutions for international governments, including health and disability assessments, program administration for employment services, wellbeing solutions, and other job seeker-related services. Maximus, Inc. was founded in 1975 and is headquartered in McLean, Virginia. Web URL: https://www.maximus.com
Additional Sources for MMS Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
MMS Stock Overview
Market Cap in USD | 4,267m |
Sector | Industrials |
Industry | Specialty Business Services |
GiC Sub-Industry | Data Processing & Outsourced Services |
IPO / Inception | 1997-06-12 |
MMS Stock Ratings
Growth 5y | 22.9% |
Fundamental | 61.4% |
Dividend | 51.4% |
Rel. Strength Industry | -146 |
Analysts | 3.5/5 |
Fair Price Momentum | 62.07 USD |
Fair Price DCF | 165.58 USD |
MMS Dividends
Dividend Yield 12m | 1.65% |
Yield on Cost 5y | 1.73% |
Annual Growth 5y | 2.05% |
Payout Consistency | 96.7% |
MMS Growth Ratios
Growth Correlation 3m | -91.5% |
Growth Correlation 12m | 33.9% |
Growth Correlation 5y | 51.4% |
CAGR 5y | 1.06% |
CAGR/Mean DD 5y | 0.08 |
Sharpe Ratio 12m | -0.65 |
Alpha | -33.96 |
Beta | 0.79 |
Volatility | 30.29% |
Current Volume | 1780.1k |
Average Volume 20d | 1145.5k |
What is the price of MMS stocks?
As of December 21, 2024, the stock is trading at USD 72.94 with a total of 1,780,064 shares traded.
Over the past week, the price has changed by +4.48%, over one month by -9.43%, over three months by -18.64% and over the past year by -9.83%.
As of December 21, 2024, the stock is trading at USD 72.94 with a total of 1,780,064 shares traded.
Over the past week, the price has changed by +4.48%, over one month by -9.43%, over three months by -18.64% and over the past year by -9.83%.
Is Maximus a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Maximus (NYSE:MMS) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 61.38 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MMS as of December 2024 is 62.07. This means that MMS is currently overvalued and has a potential downside of -14.9%.
Yes, based on ValueRay Fundamental Analyses, Maximus (NYSE:MMS) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 61.38 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MMS as of December 2024 is 62.07. This means that MMS is currently overvalued and has a potential downside of -14.9%.
Is MMS a buy, sell or hold?
Maximus has received a consensus analysts rating of 3.50. Therefor, it is recommend to hold MMS.
Maximus has received a consensus analysts rating of 3.50. Therefor, it is recommend to hold MMS.
- Strong Buy: 0
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecast for MMS stock price target?
According to ValueRays Forecast Model, MMS Maximus will be worth about 67.8 in December 2025. The stock is currently trading at 72.94. This means that the stock has a potential downside of -7.03%.
According to ValueRays Forecast Model, MMS Maximus will be worth about 67.8 in December 2025. The stock is currently trading at 72.94. This means that the stock has a potential downside of -7.03%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 114 | 56.3% |
Analysts Target Price | 100.7 | 38% |
ValueRay Target Price | 67.8 | -7% |